These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10715531)

  • 21. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.
    Lozes E; Huygen K; Content J; Denis O; Montgomery DL; Yawman AM; Vandenbussche P; Van Vooren JP; Drowart A; Ulmer JB; Liu MA
    Vaccine; 1997 Jun; 15(8):830-3. PubMed ID: 9234526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
    Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis.
    Derrick SC; Yang AL; Morris SL
    Infect Immun; 2005 Nov; 73(11):7727-35. PubMed ID: 16239577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
    Fan X; Gao Q; Fu R
    Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
    Xu J; Xu W; Chen X; Zhao D; Wang Y
    Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
    Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR
    Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis.
    Khera A; Singh R; Shakila H; Rao V; Dhar N; Narayanan PR; Parmasivan CN; Ramanathan VD; Tyagi AK
    Vaccine; 2005 Dec; 23(48-49):5655-65. PubMed ID: 16157425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis.
    Pardini M; Giannoni F; Palma C; Iona E; Cafaro A; Brunori L; Rinaldi M; Fazio VM; Laguardia ME; Carbonella DC; Magnani M; Ensoli B; Fattorini L; Cassone A
    FEMS Microbiol Lett; 2006 Sep; 262(2):210-5. PubMed ID: 16923077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection.
    Skeiky YA; Ovendale PJ; Jen S; Alderson MR; Dillon DC; Smith S; Wilson CB; Orme IM; Reed SG; Campos-Neto A
    J Immunol; 2000 Dec; 165(12):7140-9. PubMed ID: 11120845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.
    Ferraz JC; Stavropoulos E; Yang M; Coade S; Espitia C; Lowrie DB; Colston MJ; Tascon RE
    Infect Immun; 2004 Dec; 72(12):6945-50. PubMed ID: 15557616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice.
    Kalra M; Grover A; Mehta N; Singh J; Kaur J; Sable SB; Behera D; Sharma P; Verma I; Khuller GK
    Clin Immunol; 2007 Nov; 125(2):173-83. PubMed ID: 17766185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein.
    Shi C; Chen L; Chen Z; Zhang Y; Zhou Z; Lu J; Fu R; Wang C; Fang Z; Fan X
    Vaccine; 2010 Jul; 28(32):5237-44. PubMed ID: 20538090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA.
    Montgomery DL; Huygen K; Yawman AM; Deck RR; Dewitt CM; Content J; Liu MA; Ulmer JB
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):285-92. PubMed ID: 9193782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge.
    Cai H; Yu DH; Hu XD; Li SX; Zhu YX
    DNA Cell Biol; 2006 Aug; 25(8):438-47. PubMed ID: 16907641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens.
    Grover A; Ahmed MF; Singh B; Verma I; Sharma P; Khuller GK
    Microbes Infect; 2006 Aug; 8(9-10):2390-9. PubMed ID: 16962360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen.
    Bruffaerts N; Pedersen LE; Vandermeulen G; Préat V; Stockhofe-Zurwieden N; Huygen K; Romano M
    PLoS One; 2015; 10(7):e0132288. PubMed ID: 26172261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.